Biofrontera Shares Are Trading Higher After the Company Announced Top-line Results in Its Phase 3 Study of the Use of Ameluz With the BF-RhodoLED Lamp in the Treatment of SBCC.
Biofrontera Shares Are Trading Higher After the Company Announced Top-line Results in Its Phase 3 Study of the Use of Ameluz With the BF-RhodoLED Lamp in the Treatment of SBCC.
Biofrontera股价上涨，公司宣布Ameluz与BF-RhodoLED灯治疗SBCC的3期研究取得顶线结果。
Biofrontera Shares Are Trading Higher After the Company Announced Top-line Results in Its Phase 3 Study of the Use of Ameluz With the BF-RhodoLED Lamp in the Treatment of SBCC.
Biofrontera的股价走高，此前该公司公布了其关于使用Ameluz和BF-Rhodoled灯治疗SBCC的第三阶段研究的主要结果。